West Pharmaceutical Services Inc (WST)
395.71
+1.61
(+0.41%)
USD |
NYSE |
Mar 28, 16:00
395.92
+0.21
(+0.05%)
After-Hours: 20:00
West Pharmaceutical Services Free Cash Flow: 414.50M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | 414.50M |
September 30, 2023 | 420.00M |
June 30, 2023 | 396.80M |
March 31, 2023 | 410.00M |
December 31, 2022 | 439.40M |
September 30, 2022 | 387.80M |
June 30, 2022 | 401.50M |
March 31, 2022 | 382.00M |
December 31, 2021 | 330.60M |
September 30, 2021 | 341.10M |
June 30, 2021 | 287.40M |
March 31, 2021 | 307.10M |
December 31, 2020 | 298.10M |
September 30, 2020 | 272.10M |
June 30, 2020 | 277.40M |
March 31, 2020 | 247.00M |
December 31, 2019 | 240.80M |
September 30, 2019 | 215.20M |
June 30, 2019 | 200.70M |
March 31, 2019 | 185.70M |
December 31, 2018 | 183.90M |
September 30, 2018 | 192.70M |
June 30, 2018 | 172.30M |
March 31, 2018 | 166.30M |
December 31, 2017 | 132.50M |
Date | Value |
---|---|
September 30, 2017 | 104.80M |
June 30, 2017 | 83.00M |
March 31, 2017 | 68.40M |
December 31, 2016 | 49.20M |
September 30, 2016 | 48.10M |
June 30, 2016 | 67.50M |
March 31, 2016 | 77.10M |
December 31, 2015 | 80.80M |
September 30, 2015 | 76.30M |
June 30, 2015 | 72.50M |
March 31, 2015 | 61.40M |
December 31, 2014 | 70.80M |
September 30, 2014 | 78.20M |
June 30, 2014 | 66.90M |
March 31, 2014 | 84.60M |
December 31, 2013 | 64.70M |
September 30, 2013 | 74.80M |
June 30, 2013 | 73.40M |
March 31, 2013 | 31.20M |
December 31, 2012 | 55.40M |
September 30, 2012 | 26.20M |
June 30, 2012 | 19.50M |
March 31, 2012 | 25.60M |
December 31, 2011 | 33.90M |
September 30, 2011 | 50.10M |
Free Cash Flow Range, Past 5 Years
185.70M
Minimum
Mar 2019
439.40M
Maximum
Dec 2022
322.76M
Average
318.85M
Median
Free Cash Flow Benchmarks
Becton Dickinson & Co | 2.648B |
Insulet Corp | 36.50M |
Abbott Laboratories | 5.059B |
Masimo Corp | 6.40M |
Merit Medical Systems Inc | 108.45M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 239.10M |
Cash from Investing (Quarterly) | -108.80M |
Cash from Financing (Quarterly) | -189.50M |
Free Cash Flow Per Share (Quarterly) | 1.746 |
Free Cash Flow to Equity (Quarterly) | 130.90M |
Free Cash Flow to Firm (Quarterly) | 130.40M |
Free Cash Flow Yield | 1.39% |